Diego Alonso-López

9PUBLICATIONS
72CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 27, 2025
Pharmacogenomic Drug-Target Network Analysis Reveals Similarity Profiles Among FDA-Approved Cancer Drugs.

Alberto Berral-González, Monica M Arroyo, Diego Alonso-López

|Oct 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA Methylation.

Óscar Monteagudo-García, Paz Nombela, Ángel Carlos Román

|Feb 26, 2024
Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human.

Natalia García-Sancha, Roberto Corchado-Cobos, Adrián Blanco-Gómez

|Aug 24, 2023
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.

Marta Isidro-Hernández, Ana Casado-García, Ninad Oak

|Feb 08, 2022
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.

Ana Casado-García, Marta Isidro-Hernández, Ninad Oak

|Oct 07, 2020
Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.

Adrián Blanco-Gómez, Lourdes Hontecillas-Prieto, Roberto Corchado-Cobos

Pageof 2

Frequent Collaborators

5 joint publications

Javier De Las Rivas

3 joint publications

Isidro Sanchez-Garcia

3 joint publications

Carolina Vicente-Dueñas

2 joint publications

María Begoña García Cenador